ROBERT A SCOTT Insider Trading $AGIX ATHEROGENICS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ROBERT A SCOTT.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ROBERT A SCOTT. ROBERT A SCOTT is Exec VP Research & Development in ATHEROGENICS INC ($AGIX) and Exec VP, Research & Develop. in ATHEROGENICS INC ($AGIX) and Sr VP Clinical Dev & RA in ATHEROGENICS INC ($AGIX) and Sr VP Clinical Dev/Reg Affairs in ATHEROGENICS INC ($AGIX) and Sr VP Clinical Development in ATHEROGENICS INC ($AGIX) and Sr. VP Clinical Dev & RA in ATHEROGENICS INC ($AGIX).

ROBERT A SCOTT in ATHEROGENICS INC

Trading Symbol: AGIX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT A SCOTT: Exec VP, Research & Develop., Exec VP Research & Development, Sr. VP Clinical Dev & RA, Sr VP Clinical Dev/Reg Affairs, Sr VP Clinical Dev & RA, Sr VP Clinical Development
Holdings: 50,204 shares
Latest Transaction: Jun 21 2007

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ROBERT A SCOTT in ATHEROGENICS INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 21 2007	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Exec VP Research & ...	Option Exercise	A	2.41	65,728	158,404	65,728
Apr 02 2007	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Exec VP Research & ...	Buy	P	2.77	36,000	99,576	50,204	14.2 K to 50.2 K (+253.45 %)
Jan 04 2007	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Exec VP, Research & ...	Option Exercise	A	9.91	72,000	713,520	72,000
Jun 16 2006	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Exec VP Research & ...	Option Exercise	A	13.29	12,000	159,480	12,000
Jun 15 2006	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Exec VP Research & ...	Option Exercise	M	7.04	14,204	99,996	23,296
Jun 15 2006	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Exec VP Research & ...	Buy	M	7.04	14,204	99,996	14,204	0 to 14.2 K
Feb 23 2006	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Sr. VP Clinical Dev ...	Option Exercise	A	15.78	60,000	946,800	60,000
Dec 29 2005	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Sr VP Clinical Dev ...	Option Exercise	M	7.04	16,100	113,344	37,500
Dec 29 2005	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Sr VP Clinical Dev ...	Sell	S	20.01	3,900	78,026	0	3.9 K to 0 (-100.00 %)
Dec 29 2005	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Sr VP Clinical Dev ...	Sell	S	20.01	16,100	322,106	3,900	20 K to 3.9 K (-80.50 %)
Dec 29 2005	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Sr VP Clinical Dev ...	Buy	M	7.04	16,100	113,344	20,000	3.9 K to 20 K (+412.82 %)
Feb 28 2005	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Sr VP Clinical Dev/ ...	Sell	S	17.51	30,000	525,300	3,900	33.9 K to 3.9 K (-88.50 %)
Jan 04 2005	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Sr VP Clinical Dev ...	Option Exercise	A	23.56	60,000	1,413,600	60,000
Jan 23 2004	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Sr VP Clinical Deve ...	Option Exercise	M	7.41	7,500	55,575	22,500
Jan 23 2004	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Sr VP Clinical Deve ...	Option Exercise	M	7.04	4,800	33,792	53,600
Jan 23 2004	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Sr VP Clinical Deve ...	Buy	M	7.41	7,500	55,575	33,900	26.4 K to 33.9 K (+28.41 %)
Jan 23 2004	AGIX	ATHEROGENICS INC	SCOTT ROBERT A	Sr VP Clinical Deve ...	Buy	M	7.04	4,800	33,792	26,400	21.6 K to 26.4 K (+22.22 %)

Page: 1